PubMed

Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study

admin / August 14, 2025

RMD Open. 2025 Aug 14;11(3):e005557. doi: 10.1136/rmdopen-2025-005557. ABSTRACT BACKGROUND: Iscalimab (CFZ533) is a novel, anti-CD40 monoclonal antibody. This study evaluated […]

PubMed

Using ultrasound to define inflammatory and non-inflammatory phenotypes in difficult-to-treat psoriatic arthritis

admin / August 14, 2025

RMD Open. 2025 Aug 14;11(3):e005785. doi: 10.1136/rmdopen-2025-005785. ABSTRACT OBJECTIVE: To investigate the prevalence of difficult-to-treat psoriatic arthritis (D2T-PsA) and classify

PubMed

Eosinophilic Fasciitis after Covid Infection: A Case Report and Review of Literature

admin / August 14, 2025

Clin Med Res. 2025 Aug;23(2):67-71. doi: 10.3121/cmr.2025.1907. ABSTRACT Eosinophilic fasciitis (EF) is a rare fibrosing disorder caused by an autoimmune